To define the major endotypes, or pathobiological mechanisms, of embryonal rhabdomyosarcoma (ERMS) we’ve collected several human, mouse, and canine samples and clustered them together based
Scientists at cc-TDI have uncovered a drug that turns off the key gene in childhood muscle cancer. [Press Release] PORTLAND, OR – NOVEMBER 20, 2018
The last 6 months have been busy! Recently, I have been finishing up sets of experiments which help us understand the mode of action
My name is Dr. Tohru Hosoyama, Ph.D., and I am the section chief of the Department of Regenerative Medicine at National Center for Geriatrics and
At the end of August I took a trip to Portland, Oregon to take an intensive 5-day “Pediatric Cancer Nanocourse” at the cc-TDI lab (where
I’ll never forget the moment I found out that my cousin had cancer. It’s one of those moments you remember exactly where you were and
What a week! Our 2018 Nanocourse wrapped up last week, and what an amazing week it was. For those of you who are curious, the
Each week we will be featuring the work of a scientist on the cc-TDI team to give you a view into the lab and an
In a groundbreaking collaboration, 10 family groups from around the world have raised $250,000 to fund the preclinical validation of a key drug discovered in
Each week we will be featuring the work of a scientist on the cc-TDI team to give you a view into the lab and an
To define the major endotypes, or pathobiological mechanisms, of embryonal rhabdomyosarcoma (ERMS) we’ve collected several human, mouse, and canine samples and clustered them together based
Scientists at cc-TDI have uncovered a drug that turns off the key gene in childhood muscle cancer. [Press Release] PORTLAND, OR – NOVEMBER 20, 2018
The last 6 months have been busy! Recently, I have been finishing up sets of experiments which help us understand the mode of action
My name is Dr. Tohru Hosoyama, Ph.D., and I am the section chief of the Department of Regenerative Medicine at National Center for Geriatrics and
At the end of August I took a trip to Portland, Oregon to take an intensive 5-day “Pediatric Cancer Nanocourse” at the cc-TDI lab (where
I’ll never forget the moment I found out that my cousin had cancer. It’s one of those moments you remember exactly where you were and
What a week! Our 2018 Nanocourse wrapped up last week, and what an amazing week it was. For those of you who are curious, the
Each week we will be featuring the work of a scientist on the cc-TDI team to give you a view into the lab and an
In a groundbreaking collaboration, 10 family groups from around the world have raised $250,000 to fund the preclinical validation of a key drug discovered in
Each week we will be featuring the work of a scientist on the cc-TDI team to give you a view into the lab and an
EIN: 46-5759569
cc-TDI is a qualified 501(c)(3) charitable organization registered with the IRS
(consult with a CPA regarding specific tax implications)
Copyright 2019 – Children’s Cancer Therapy Development Institute